Cybin Inc. to Present at H.C. Wainwright Conference
Ticker: HELP · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1833141
Sentiment: neutral
Topics: conference-participation, biotech, psychedelics
TL;DR
Cybin CEO Drysdale presenting at H.C. Wainwright conference June 17th, 10:30 AM ET.
AI Summary
Cybin Inc. announced on June 12, 2025, its participation in the H.C. Wainwright Neo-Securities Conference. CEO Doug Drysdale is scheduled to present on June 17, 2025, at 10:30 AM ET, providing an overview of the company's progress in psychedelic-based therapeutics.
Why It Matters
This presentation offers investors and the public an opportunity to hear directly from leadership about the company's advancements in the developing field of psychedelic medicine.
Risk Assessment
Risk Level: medium — Participation in industry conferences is standard, but the speculative nature of psychedelic therapeutics introduces inherent risks.
Key Players & Entities
- Cybin Inc. (company) — Registrant
- Doug Drysdale (person) — Chief Executive Officer
- H.C. Wainwright Neo-Securities Conference (company) — Conference host
- June 17, 2025 (date) — Presentation date
- 10:30 AM ET (time) — Presentation time
FAQ
What is the specific date and time of Cybin's presentation?
Cybin's presentation is scheduled for June 17, 2025, at 10:30 AM ET.
Who will be presenting on behalf of Cybin Inc.?
Doug Drysdale, Chief Executive Officer of Cybin Inc., will be presenting.
Which conference will Cybin Inc. be participating in?
Cybin Inc. will be participating in the H.C. Wainwright Neo-Securities Conference.
What is the purpose of Cybin's participation in the conference?
The purpose is for Cybin to present and provide an overview of the company's progress in psychedelic-based therapeutics.
What is the filing date of this Form 6-K?
This Form 6-K was filed on June 12, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 by Doug Drysdale regarding CYBIN INC. (HELP).